Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2021	Aug. 01, 2020
Cash flows from operating activities:
Net income (loss)	$ 33,148	$ (52,440)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Amortization of deferred debt issuance costs	328	72
Impairment of assets	(1,017)	16,335
Depreciation and amortization	8,889	11,072
Stock compensation expense	643	797
Board of directors stock compensation	219	149
Changes in operating assets and liabilities:
Accounts receivable	4,406	3,645
Inventories	11,660	15,032
Prepaid expenses and other current assets	(1,901)	975
Other assets	34	622
Accounts payable	(7,214)	(13,230)
Operating leases, net	(9,781)	4,487
Accrued expenses and other liabilities	2,829	3,488
Net cash provided by (used for) operating activities	42,243	(8,996)
Cash flows from investing activities:
Additions to property and equipment, net	(1,723)	(2,128)
Net cash used for investing activities	(1,723)	(2,128)
Cash flows from financing activities:
Proceeds from issuance of common stock from private direct offering, net of offering costs	4,375
Net borrowings (repayments) under credit facility	(59,733)	27,225
Debt issuance costs	(818)	(25)
Proceeds from the exercise of stock options	4
Net cash provided by (used for) financing activities	(53,672)	27,200
Net increase (decrease) in cash and cash equivalents	(13,152)	16,076
Cash and cash equivalents:
Beginning of period	18,997	4,338
End of period	5,845	$ 20,414
FILO Loan
Cash flows from financing activities:
Repayment of existing FILO loan	(15,000)
Proceeds from new FILO loan	$ 17,500